Holen Sie sich die Stockscreener-App
3.00
5.10%
-0.14
Handel nachbörslich:
3.06
0.06
+2.00%
Finanzdaten der Nrx Pharmaceuticals Inc-Aktie (NRXP)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2025-03-31 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Revenues |
-
|
- | - | - | - |
| Income/Loss From Continuing Operations Before Tax |
30.20%
-5.512
|
-7.897 | -6.528 | -4.332 | -6.062 |
| Income Tax Expense/Benefit |
-
|
- | - | - | - |
| Income/Loss From Continuing Operations After Tax |
30.20%
-5.512
|
-7.897 | -6.528 | -4.332 | -6.062 |
Net Income/Loss
|
30.20%
-5.512
|
-7.897 | -6.528 | -4.332 | -6.062 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
2.47%
0.34%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):